[Use of a new antimicrobial preparation baliz-2 in inflammatory diseases of paranasal sinuses].
Conservative therapy of 104 patients with acute and chronic sinusitis included a new antimicrobial drug--Balis-2--administered into the affected sinuses. After 1 to 3 punctures the recovery was observed in all patients (34 patients) with acute sinusitis and in 54 out of 70 patients (77.1%) with chronic sinusitis. Balis-2 is recommended for a wide application in the therapy of sinusitis.
Semenov
F V
FV
Budko
V M
VM
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D005626:Frontal Sinus; D006801:Humans; D007651:Keto Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008443:Maxillary Sinus; D008875:Middle Aged; D012852:Sinusitis / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D007651:Keto Acids; C057854:baliz 2
Primenenie novogo antimikrobnogo preparata baliz-2 pri vospalitel'nykh zabolevaniiakh okolonosovykh pazukh.